Qualigen Therapeutics announces 1-for-50 reverse stock split to regain Nasdaq compliance

AIxCrypto Holdings, Inc.

Effective Nov 5, 2024, at 12:01 a.m. ET; trading on split-adjusted basis from market open.
Reverse split ratio 1-for-50; reduces shares from ~36.7M to ~737k.
Approved by stockholders Oct 25, 2024; board set ratio same day.
Purpose: increase bid price to regain Nasdaq minimum bid price requirement.
Cash for fractional shares; no change in authorized shares or par value; new CUSIP 74754R 301.

item 5.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

AIxCrypto Holdings, Inc.: Effect a 1-for-50 reverse stock split of common stock (effective 2024-11-05).

Change: charter amendment
Effective: 2024-11-05

Exact text from the filing

On October 28, 2024, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding Common Stock, effective November 5, 2024 at 12:01 a.m., Eastern Time (the “Effective Time”).

View on SEC.gov

188 governance changes filed in the last 30 days. Browse all governance changes →

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-043352

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.